BioNTech, Pfizer say 3 vaccine doses neutralise Omicron variant

BioNTech and Pfizer said on Wednesday a three-shot course of their Covid-19 vaccine was shown to generate a neutralising effect against the new Omicron variant in a laboratory test.

In a joint statement that two vaccine doses resulted in significantly lower neutralising antibodies but a third dose of their vaccine increased the neutralising antibodies by a factor of 25. They added that, if needed, they can deliver an Omicron-based vaccine in March 2022.


Khaleej Times

Related Articles

Back to top button